Work

Post-Progression Therapy after Chemoradiation and Consolidation Pembrolizumab: An Analysis from the Hoosier Cancer Research Network LUN 14-179 Phase 2 Clinical Trial

Year: 2020

Type: article

Authors: Meagan Miller, Nasser H. Hanna, Shadia I. Jalal, Salma K. Jabbour, Robin Zoň, Goetz Kloecker, Michael Williamson, Karen L. Reckamp, Ebenezer A. Kio, Robert M. Langdon, Bamidele Adesunloye, Ryan D. Gentzler, Wael A. Harb, Radhika Walling, Christina Yeon, Marianna Koczywas, Greg Andrew Durm

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3130148590

FWCI:

Cites:

Cited by:

Related to: 10